TargetCancer Foundation Executive Director Jim Palma will supply an introduction of the TRACK scientific trial, which is presently registering clients with unusual cancers consisting of cholangiocarcinoma. Clients registered in TRACK get biomarker screening of tissue and blood through Foundation Medicine, in addition to treatment suggestions from a nationwide panel of physicians and researchers.
http://phlebotomycareertraining.org/webinar-an-introduction-of-the-tcf-001-track-target-rare-cancer-knowledge-scientific-trial/
No comments:
Post a Comment